ZA817718B - Macrolide antibiotics - Google Patents

Macrolide antibiotics

Info

Publication number
ZA817718B
ZA817718B ZA817718A ZA817718A ZA817718B ZA 817718 B ZA817718 B ZA 817718B ZA 817718 A ZA817718 A ZA 817718A ZA 817718 A ZA817718 A ZA 817718A ZA 817718 B ZA817718 B ZA 817718B
Authority
ZA
South Africa
Prior art keywords
macrolide antibiotics
macrolide
antibiotics
Prior art date
Application number
ZA817718A
Other languages
English (en)
Inventor
Richard Henry Baltz
Herbert Andrew Kirst
Gene Muriel Wild
Eugene Thomas Seno
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA817718B publication Critical patent/ZA817718B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/54Streptomyces fradiae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/896Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA817718A 1980-11-10 1981-11-09 Macrolide antibiotics ZA817718B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/205,539 US4304856A (en) 1980-11-10 1980-11-10 Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin

Publications (1)

Publication Number Publication Date
ZA817718B true ZA817718B (en) 1982-10-27

Family

ID=22762621

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA817718A ZA817718B (en) 1980-11-10 1981-11-09 Macrolide antibiotics

Country Status (22)

Country Link
US (1) US4304856A (xx)
EP (1) EP0052005B1 (xx)
JP (1) JPS57108097A (xx)
KR (1) KR850001666B1 (xx)
AR (1) AR227563A1 (xx)
AU (1) AU7731381A (xx)
BG (1) BG36939A3 (xx)
CA (1) CA1169374A (xx)
CS (1) CS236663B2 (xx)
DD (1) DD202032A5 (xx)
DE (1) DE3168693D1 (xx)
DK (1) DK494381A (xx)
FI (1) FI813527L (xx)
GB (1) GB2086902B (xx)
GR (1) GR75386B (xx)
HU (1) HU190360B (xx)
IE (1) IE51826B1 (xx)
IL (1) IL64240A (xx)
PH (1) PH17375A (xx)
PL (1) PL233747A1 (xx)
PT (1) PT73947B (xx)
ZA (1) ZA817718B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419508A (en) * 1980-11-10 1983-12-06 Eli Lilly And Company 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives
US4423148A (en) * 1982-07-02 1983-12-27 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4528369A (en) * 1982-07-02 1985-07-09 Eli Lilly And Company 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4452784A (en) * 1982-07-19 1984-06-05 Eli Lilly And Company C-23-Modified derivatives of DMT
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
WO1995002594A1 (en) * 1993-07-15 1995-01-26 Pfizer Inc. Amide derivatives of 16-membered ring antibiotic macrolides
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
US3344024A (en) * 1963-04-17 1967-09-26 American Cyanamid Co Antibiotic am-684 and method of production
BE667952A (xx) * 1964-08-05
US4161523A (en) * 1972-11-15 1979-07-17 Schering Corporation Rosamicin esters, acid addition salts and methods for production thereof
US4056616A (en) * 1976-03-05 1977-11-01 Schering Corporation Rosamicin derivatives and method of using same
GB1587685A (en) * 1977-03-09 1981-04-08 Microbial Chem Res Found Macrolactone derivatives and their production
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.

Also Published As

Publication number Publication date
HU190360B (en) 1986-08-28
IL64240A (en) 1985-08-30
EP0052005B1 (en) 1985-01-30
FI813527L (fi) 1982-05-11
CS236663B2 (en) 1985-05-15
EP0052005A1 (en) 1982-05-19
PT73947B (en) 1983-11-30
CA1169374A (en) 1984-06-19
DD202032A5 (de) 1983-08-24
BG36939A3 (en) 1985-02-15
JPS57108097A (en) 1982-07-05
PT73947A (en) 1981-12-01
PH17375A (en) 1984-08-06
GB2086902B (en) 1985-06-26
KR830007833A (ko) 1983-11-07
PL233747A1 (xx) 1982-11-22
IL64240A0 (en) 1982-02-28
US4304856A (en) 1981-12-08
GB2086902A (en) 1982-05-19
AR227563A1 (es) 1982-11-15
DE3168693D1 (en) 1985-03-14
KR850001666B1 (ko) 1985-11-13
IE51826B1 (en) 1987-04-01
IE812616L (en) 1982-05-10
GR75386B (xx) 1984-07-13
DK494381A (da) 1982-05-11
AU7731381A (en) 1982-05-20

Similar Documents

Publication Publication Date Title
GB2077731B (en) Macrolide antibiotics
JPS5657797A (en) Antibiotic uu59761
ZA827721B (en) Antibiotic
AU565892B2 (en) C-20-modified macrolide antibiotics
DE3168693D1 (en) Macrolide antibiotics
ZA815183B (en) Macrolides
GB8324134D0 (en) Antibiotic acmimycin
IL63312A0 (en) Macrolide antibiotics
JPS5781488A (en) 1-oxa-beta-lactam antibiotic
JPS5754591A (en) Antibiotics u-43120
GB2089815B (en) Antibiotic a-4696 factor g
GB2124226B (en) Antibiotic
GB2061946B (en) Macrolide antibiotic
GB2056985B (en) Antibiotic em4940
DE3273313D1 (en) Antibiotics
IE802326L (en) Macrolide antibiotics
GB8426115D0 (en) Antibiotic ll-c23024
DE3166479D1 (en) Macrolides
DE3170183D1 (en) Antibiotic 5057b
JPS5781413A (en) Didemnin antibiotic
IE802226L (en) ß-LACTAMS; ANTIBIOTICS
GB2113672B (en) Antibiotic
GB2042501B (en) Antibiotic ax-127b-1
GB2059946B (en) Antibiotic ncs-c
EP0064555A4 (en) ANTIBIOTIC 5057 B.